ACUTA CAPITAL PARTNERS, LLC Portfolio

Auto-discovered active 13F filer.

SEC 13F CIK: 0001582844

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallFocusedHealth TiltHigh Turnover how tags are computed

Q4 2025 · 30 positions · Total reported value $147.29M · Top-10 concentration 79.4% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 52.9% · 11 new · 7 cut · 0 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -16.4% · vs SPY -18.5% · Prev Value $143.49M — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -8.3% · vs SPY -10.5% · Latest Value $126.75M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q4 2025 13F filing, ACUTA CAPITAL PARTNERS, LLC disclosed 30 equity positions with a combined reported value of $147.29M. The filing implies a focused portfolio: its ten largest positions account for 79.4% of reported value. HoldingsHub classifies the profile as Small / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q4 2025 were TERN ($25.74M), PRAX ($24.47M), CDTX ($19.69M). By sector, the heaviest allocations are Health Care 69.1%, Other 30.9%.

Versus the prior quarter, ACUTA CAPITAL PARTNERS, LLC opened 11 new positions, trimmed 7 and fully exited 0, a turnover rate of 52.9% of positions. The portfolio's overlap with the prior quarter was 66% of names.

The largest new positions opened in Q4 2025 were NERV ($2.85M), TNGX ($2.51M), DSGN ($1.42M).

Of the 5 positions fully exited versus the prior quarter, the largest were TRML ($12.84M), ASND ($1.95M), KRYS ($1.87M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q4 2025)

  • NERV MINERVA NEUROSCIENCES INC · $2.85M
  • TNGX TANGO THERAPEUTICS INC · $2.51M
  • DSGN DESIGN THERAPEUTICS INC · $1.42M
  • MAZE MAZE THERAPEUTICS INC · $828.60K
  • MLTX MOONLAKE IMMUNOTHERAPEUTICS · $781.31K
  • STRO SUTRO BIOPHARMA INC · $780.41K
  • KTTA PASITHEA THERAPEUTICS CORP · $580.50K

Fully Exited (vs previous quarter)

  • TRML TOURMALINE BIO INC · prev qtr: $12.84M
  • ASND ASCENDIS PHARMA A/S · prev qtr: $1.95M
  • KRYS KRYSTAL BIOTECH INC · prev qtr: $1.87M
  • COGT COGENT BIOSCIENCES INC · prev qtr: $1.48M
  • FULC FULCRUM THERAPEUTICS INC · prev qtr: $525.70K

Insider Transactions (Form 4)

Latest ACUTA CAPITAL PARTNERS, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Acuta Capital Partners, based in Redwood City, CA, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 23 positions worth $143.49M in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: REDWOOD CITY, CA, United States
  • SEC registration: 801-136966 (status: Approved), registered 2026-09-09
  • Regulatory AUM (Form ADV): $172.53M as of 2026-06-30
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 2 private funds, of which 2 hedge funds
  • Website: acutacapital.com

Portfolio Structure

  • 23 positions · $143.49M reported value (Q2 2026)
  • Top 10 holdings = 73.7% of reported value
  • Largest position: PRAX (PRAXIS PRECISION MEDICINES I) at 19.3%
  • Average position size: $6.24M

Sector Tilt

  • Health Care 100.0%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 4 new, 7 added, 6 reduced, 7 exited
  • 6 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 69.1%
Other 30.9%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 637.10K $25.74M 17.48%
17.48%
Add
2 83.04K $24.47M 16.62%
16.62%
Add
3 89.14K $19.69M 13.37%
13.37%
Reduce
4 1.05M $12.78M 8.68%
8.68%
Reduce
5 3.41M $8.25M 5.60%
5.60%
Hold
6 84.48K $6.59M 4.48%
4.48%
Hold
7 1.09M $5.87M 3.99%
3.99%
Add
8 29.01K $4.93M 3.35%
3.35%
Add
9 25.88K $4.50M 3.06%
3.06%
Reduce
10 4.85K $4.08M 2.77%
2.77%
Reduce
11 178.41K $4.03M 2.74%
2.74%
Hold
12 333.26K $4.03M 2.73%
2.73%
Hold
13 709.50K $2.85M 1.94%
1.94%
New
14 282.73K $2.51M 1.70%
1.70%
New
15 454.83K $2.50M 1.70%
1.70%
Hold
16 80.14K $2.11M 1.43%
1.43%
Hold
17 101.78K $2.03M 1.38%
1.38%
Hold
18 150.91K $1.42M 0.96%
0.96%
New
19 16.38K $1.29M 0.88%
0.88%
Hold
20 2.30K $1.12M 0.76%
0.76%
Hold
21 143.45K $1.11M 0.75%
0.75%
Hold
22 20.00K $828.60K 0.56%
0.56%
New
23 59.28K $781.31K 0.53%
0.53%
New
24 67.45K $780.41K 0.53%
0.53%
New
25 16.71K $688.54K 0.47%
0.47%
Reduce
26 8.41K $669.94K 0.46%
0.46%
Hold
27 30.00K $667.80K 0.45%
0.45%
Hold
28 450.00K $580.50K 0.39%
0.39%
New
29 59.98K $346.11K 0.23%
0.23%
Hold
30 90.83K $29.98K 0.02%
0.02%
Hold

FAQ

What did ACUTA CAPITAL PARTNERS, LLC buy in 2025-Q4?

In its 2025-Q4 13F filing, ACUTA CAPITAL PARTNERS, LLC reported 30 equity positions worth $147.29M in aggregate; its largest disclosed positions were TERN ($25.74M), PRAX ($24.47M), CDTX ($19.69M).

How large is ACUTA CAPITAL PARTNERS, LLC's portfolio?

ACUTA CAPITAL PARTNERS, LLC reported $147.29M of long equity holdings across 30 positions as of 2025-Q4. Top-10 holdings account for 79.4% of reported value.

What is ACUTA CAPITAL PARTNERS, LLC's investment style?

HoldingsHub classifies the portfolio as Small / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/acuta-capital-partners/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →